Document Detail

Primary patency with cutting and conventional balloon angioplasty for different types of hemodialysis access stenosis.
MedLine Citation:
PMID:  17400756     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To compare primary patency rates of cutting balloon percutaneous transluminal angioplasty (PTA) (hereafter, cutting PTA) and conventional balloon PTA (hereafter, conventional PTA) in the treatment of different types of hemodialysis access stenosis. MATERIALS AND METHODS: The institutional review board approved this study. Written informed consent was obtained for the prospective component of this study and waived for the retrospective component. Patients in whom treatment with cutting PTA alone or conventional PTA alone was clinically successful formed the two study groups. Primary patency for the lesion was defined as uninterrupted patency of the treated site after balloon PTA. A site was no longer considered patent when the patient underwent treatment for hemodialysis access failure due to restenosis of the treated site. Primary patency rates for lesions were calculated with the Kaplan-Meier method according to the type of stenosis. We compared the two groups by using the log-rank test to determine statistical significance. RESULTS: In the cutting PTA group, 62 patients with 77 stenoses (32 men, 30 women; mean age, 65.5 years +/- 10.1 [standard deviation]) achieved clinical success. In the conventional PTA group, 52 patients with 68 stenoses (23 men, 29 women; mean age, 61.9 years +/- 10.2) achieved clinical success. In patients with autogenous venous stenosis, no significant difference in the primary patency rate was noted between groups (P = .369). In patients with graft-to-vein anastomotic stenosis, the primary patency rate was significantly higher for cutting PTA than for conventional PTA (P = .39). In patients with intragraft stenosis, no significant difference in the primary patency rate was noted between groups (P = .379). In patients with in-stent restenosis, no significant difference in the primary patency rate was noted between groups (P = .923). CONCLUSION: Primary patency rates are significantly higher for cutting PTA in the treatment of graft-to-vein anastomotic stenosis; however, no significant differences in primary patency rates exist between these PTAs in the treatment of autogenous venous stenosis, intragraft stenosis, or in-stent restenosis.
Shuji Kariya; Noboru Tanigawa; Hiroyuki Kojima; Atsushi Komemushi; Yuzo Shomura; Tomokuni Shiraishi; Toshiaki Kawanaka; Satoshi Sawada
Related Documents :
21061246 - Single center experience with percutaneous endovascular repair of superior vena cava sy...
24142756 - The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterol...
18506126 - Day-case angioplasty in diabetic patients with critical ischemia.
9685136 - Does stent placement improve the results of ineffective or complicated iliac artery ang...
19651956 - Stability of cemented in-line pegged glenoid compared with keeled glenoid components in...
24106686 - A preliminary study: aspirin discontinuation before elective operations; when is the op...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article     Date:  2007-03-30
Journal Detail:
Title:  Radiology     Volume:  243     ISSN:  0033-8419     ISO Abbreviation:  Radiology     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-04-25     Completed Date:  2007-05-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  578-87     Citation Subset:  AIM; IM    
Department of Radiology, Kansai Medical University, Moriguchi, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon / methods*
Arteriovenous Shunt, Surgical / methods*
Catheters, Indwelling / adverse effects*
Graft Occlusion, Vascular / etiology*,  prevention & control*
Middle Aged
Renal Dialysis / adverse effects*
Treatment Outcome
Vascular Patency*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria v...
Next Document:  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coeffi...